![]() | ![]() |
Formats:
|
||||||||||||||||||||
Dissection of the Bacteriophage T4 Late Promoter Complex Division of Biological Sciences and Center for Molecular Genetics, University of California, San Diego 9500 Gilman Drive La Jolla, CA 92093-0634 *Scientific correspondence may be addressed to SN (nechaevs/at/niehs.nih.gov) or EPG (epg/at/biomail.ucsd.edu). †Current address: Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, 111 T.W. Alexander Drive, Room D434, Research Triangle Park, NC 27709, Tel: (919) 541-3525; Fax: (919) 541-0146 The publisher's final edited version of this article is available at J Mol Biol. See other articles in PMC that cite the published article.Abstract Activated transcription of the bacteriophage T4 late genes is generated by a mechanism that stands apart from the common modalities of transcriptional regulation: the activator gp45 is the viral replisome’s sliding clamp; two sliding clamp-binding proteins, gp33 and gp55, replace the host RNA polymerase (RNAP) σ subunit. We have mutagenized, reconfigured and selectively disrupted individual interactions of the sliding clamp with gp33 and gp55 and have monitored effects on transcription. The C-terminal sliding clamp-binding epitopes of gp33 and gp55 are perfectly interchangeable, but the functions of these two RNAP-sliding clamp connections differ, with only the gp33-gp45 linkage essential for activation. Formation of transcription-ready promoter complexes by the sliding clamp-activated wild-type T4 RNAP resists competition by high concentrations of the polyanion heparin. This avid formation of promoter complexes requires both linkages of the T4 late RNAP to the sliding clamp. Preopening the promoter compensates for loss of the gp55-gp45 but not the gp33-gp45 linkage. We interpret these findings in relation to the common model of transcriptional initiation in bacteria and highlight the roles of individual interactions of the promoter complex. Keywords: RNA polymerase, promoter, gene regulation, phage T4, sliding clamp Introduction Interaction of RNA polymerase (RNAP) with promoters is a multistep process that includes selection of a promoter among other sequences, promoter binding and, ultimately, formation of the transcriptionally competent, open complex (Record et al, 1996). Most bacterial promoters are defined by two short sequence motifs positioned 35 and 10 base pairs (bp) upstream of the start point of transcription. Promoters are recognized by the promoter specificity subunit (s) of the RNA polymerase holoenzyme through sequence-specific interactions of s domain 4 (bound to the flap of the RNAP b subunit) with the -35 motif, and domain 2 (bound to the RNAP b’ subunit coiled coil) with the -10 motif. Additional interactions, of the two RNAP a subunit C-terminal domains (aCTDs) with DNA upstream of position ~-40, and of other regions of s with DNA near the start point of transcription, influence promoter strength and play important regulatory roles (Haugen et al, 2006; Ross et al, 1993; Wilson and Dombroski, 1997; Zenkin et al, 2007). Transcription of the bacteriophage T4 late genes is regulated by a mechanism that stands apart from the known modalities of transcriptional regulation. First, the late genes are served by promoters consisting solely of an 8-bp motif (consensus sequence TATAAATA) centered 10 bp upstream of the transcriptional start site. Transcription initiating at the ~40 T4 late promoters utilizes the host cell’s RNAP core, modified (Walter et al, 1968) to inactivate interaction of its two αCTDs with DNA (by ADP-ribosylation of Arg265 in the DNA-presentation helix) and bearing two small phage-encoded subunits, the gene 33 and gene 55 products (gp33 and gp55). Second, the RNAP β’ coiled coil and β flap of the T4 late holoenzyme are occupied by separate proteins: gp55 and gp33 bind to the RNAP core at sites that are the principal attachment points of σ70 domain 2 (Wong et al, 2003) and domain 4 (Nechaev et al, 2004), respectively. Gp55 is the promoter recognition subunit of T4 late transcription and gp55-RNAP holoenzyme suffices for accurately initiating basal late transcription in vitro (Kassavetis and Geiduschek, 1984); a limited similarity of gp55 residues ~42-122 with σ70 domain 2 can be discerned (Gribskov and Burgess, 1986). Gp33 is the essential coactivator (Herendeen et al, 1990) of the high-level T4 late gene transcription that is required for producing the massive quantities of structural proteins that assemble into progeny virions during the final minutes of the phage multiplication cycle (Epstein et al, 1963). There is no similarity of amino acid sequence between gp33 and σ70 domain 4. Third, T4 late transcription in vivo is coupled to concurrent DNA replication through a unique transcriptional activator, the DNA-loaded sliding clamp, gp45 (Herendeen et al, 1992; Tinker et al, 1994a; Tinker et al, 1994b). Gp45, a head-to-tail trimer with a central annulus that is lined with positively charged side chains and accommodates double-stranded DNA, interacts with the similar acidic and hydrophobic C-terminal motifs of its ligands—gp55, gp33 and the T4 DNA polymerase gp43 (Figure 1A
In this work, we have selectively disrupted individual interactions of the gp45 sliding clamp with gp33 and gp55, and monitored the effects on transcription. Our findings allow us to interpret the mechanism of T4 late transcription in terms of the common model of transcriptional initiation in bacteria and to highlight the roles of individual interactions in the promoter complex. Results The functional asymmetry of gp55 and gp33 interactions with the sliding clamp The gp45 sliding clamp binds to the T4 late promoter complex through interactions with the highly similar C-ends of gp55 and gp33 (Figure 1A The first experiment examines the effect on transcription of eliminating either or both of these interactions with gp45 by removing the 5 and 8 C-terminal amino acids of gp33 and gp55, respectively (Figure 1B
To determine the significance of the gp45-33 linkage in activation, we probed the ability of gp45 to activate transcription in reactions from which gp33 (and not just the gp45-33 connection) was absent altogether. In the absence of gp33, the gp55-gp45 interaction generated at most only a modest increase of transcription above the basal level (Figure 1C Thus, the principal finding of this experiment is that eliminating the interactions of gp55 and gp33 with the sliding clamp has entirely different consequences, suggesting that these two linkages play different roles in transcriptional activation. The C-terminal interaction motifs of gp33, gp55 and gp43 are interchangeable The similar C-terminal motifs of gp33, gp55 and gp43 are necessary for binding to gp45 in solution; the C-termini of gp55 as well as gp43 are also sufficient for gp45 binding (Alley et al, 1999; Wong and Geiduschek, 1998). To test the functional equivalence of these motifs, they were exchanged in gp55 and gp33 in all combinations and tested for compatibility with transcriptional activation. The results of one such experiment are shown in Figure 2A
The replacement of both of the gp55 and gp33 C-terminal motifs by the gp43 motif is of special interest because the gp43-gp45 interaction has been extensively characterized (Trakselis et al, 2001). An experiment to compare promoter opening of this combination with the wild type is shown in Figure 2B Activation sustained solely by the gp33-gp45 interaction The characteristics of this “one-armed” activation were further examined in an experiment that exploited the following properties of T4 late transcription. First, fully activated transcription with wild-type gp55 and gp33 is robust, in the sense that it is unaffected by PEG and manifested with T4-modified as well as unmodified RNAP (RNAPT4 and RNAPU, respectively) (Figure 3A
With RNAPU core and in the absence of the gp55-gp45 interaction (CΔ8gp55 holoenzyme), the gp33-gp45 interaction increased transcription in PEG-containing reaction medium but had no effect on transcription in the absence of PEG (Figure 3 C, D Notably, sliding clamp activation of transcription sustained solely by the gp33-gp45 interaction was significantly lower than fully activated transcription (compare panels A and C), indicating the importance of both the gp45-gp55 and the gp45-gp33 interactions. We indicate below that the two interactions with the sliding clamp play nonoverlapping roles, but the data to this point make one distinction clear: barring interference by the αCTD, the gp33-sliding clamp linkage partially activates transcription by gp55-RNAP, while the gp55-sliding clamp linkage does not exert a significant effect. When there is interference by the αCTD, as with RNAPU in the absence of PEG, one-armed activation is ineffective and transcription does not rise above the basal level (Supplemental Figure 3). Mutational analysis of the gp33 and gp55 linkages to the sliding clamp The gp33 and gp55 segments that link the C-terminal epitopes with the rest of the protein are divergent, even among the T-even family phages that are capable of infecting E. coli (Supplemental Figure 1). Accordingly, they might be thought of as nonspecific linkers for attaching the sliding clamp to the late promoter complex. We have subjected these connector segments to mutagenesis. The original objective was to examine constraints on their lengths, but the analysis has yielded additional insights into their functional and structural characteristics. Effects of mutations on transcriptional activation were assessed, with RNAPU in PEG-containing reaction medium, by measuring the rate of promoter opening for single rounds of transcription (Figure 4
For gp55, small deletions or insertions in the linker, for example removing residues 162-165 (TPGA) or adding SGGGC after residue 165 (165ins5), did not significantly affect transcriptional activation (Supplemental Figure 5A). More extensive substitutions of sequence within this segment were also without substantial effect on activated transcription under the assayed conditions. For example, removing residues 159-165 (TYRTPGA) reduced transcription to the same level as removing the C-terminal epitope, consistent with the connector to the sliding clamp having been excessively shortened. Replacing these 7 residues with the flexible 7-amino acid linker SGGGCSG (Δ159-165-ins7) restored essentially full activity (Supplemental Figure 4B). The gp55 double mutant P163A/P175A was also fully competent for transcriptional activation (data not shown). Even replacement of the entire residue 159-175 segment with the simple 17-residue linker (SG)8C allowed retention of a very substantial level of activated transcription when assayed at polymerase excess (Figure 4A Comparable changes of the gp33 connector severely impaired transcriptional activation. For example, inserting the 5-residue flexible linker SGGGC between residues 101 and 102 severely diminished activation (Supplemental Figure 5C). Deleting residues 98-102 (SVVRC) was also strongly deleterious, and replacement with a flexible linker (SGGGC) was not tolerated (data not shown). A double-alanine substitution scan also showed the sensitivity of gp33 function to changes in the residue 92-107 segment (Supplemental Figure 4), with the largest effect of AA substitution at residues 94-97 (L94A/L95A and R96A/P97A), minimal effects of substitution at residues 100 and 101 (V100A/R101A), and substantial sensitivity to substitution at residues 102-105 (C102A/E103A and K104A/T105A). These double-alanine substitutions did also affect polymerase core binding but, at the high molar excess (12X) of gp33 over core enzyme that was used for the activation assay, deficiencies of core occupancy would not account entirely for the observed effects on transcriptional activation (Supplemental Figure 4). The principal conclusion to be drawn from these experiments is that the gp55 connector is at least partly unstructured and flexible and that it tolerates lengthening. Requiring the gp55 linker to span the space between the sliding clamp and the body of gp55-RNAP in the activated promoter complex imposes a minimum length requirement. Extensive amino acid substitution of the gp55 linker is compatible with transcriptional activation and flexibly extending the linker is also tolerated. In contrast, the gp33 connector is highly constrained and mutations therein affect transcriptional activation as well as core binding functions. Avid formation of the activated T4 late promoter complex Heparin (Walter et al, 1967) and other polyanions bind RNAPs and are commonly used as competitive inhibitors of transcription. In the extensive analysis of the phage λPR and lacUV5 promoters that establishes the general kinetic scheme of the reaction pathway to initiation of transcription (Record et al, 1996), heparin has been used to trap free RNAP while leaving stably bound (isomerized), closed as well as open promoter complexes untouched, at least over limited periods of time. That heparin also directly attacks certain preformed, open σ70 promoter complexes was originally shown for the very strong phage T7A1 early promoter (Pfeffer et al, 1977) and has also been noted for the rrnB promoter (Barker, 2001). It was therefore unexpected to find the outcome of the experiment summarized in Figure 5A
In view of the newly identified avid formation of activated T4 late promoter complexes, 2 σ70 promoters were also tested: T7A1 (with UP, -35 and -10 sites) and E-10con, a galP1-based promoter with only a consensus extended -10 site. Under the same reaction conditions as above, preformed E-10con promoter complexes were stable (Figure 6A Interactions with the sliding clamp and promoter opening The next experiment explores whether losses of transcriptional activation (Figure 1
Preopening the promoter rescued the transcription defect generated by disconnecting gp33 from the sliding clamp (compare transcript T1 in lanes 19 and 9) and, less drastically, the deficits of the other two mutants (compare lanes 17, 15 and 13 with lanes 7, 5 and 3, respectively). Promoter preopening restored avid formation to transcription complexes lacking the gp55-sliding clamp linkage (compare lanes 16 and 6) but not complexes lacking the gp33-sliding clamp linkage (compare lanes 20 and 19), or basal transcription complexes (lane 12). The ability to rescue the deleterious effect of the gp55CΔ8 mutation by preopening the promoter implies that loss of the gp55-gp45 connection affects a late step along the reaction pathway leading to initiation of transcription (i.e., following recruitment of RNAP to the promoter). The two gp33 mutations affecting the linkage to the sliding clamp respond differently to promoter preopening. Restoration of activated transcription to both mutants by preopening the promoter would be consistent with the gp33-gp45 connection also affecting a late step in transcriptional initiation. However, avid formation of open complexes was only restored to the gp33 5-residue insertion mutant (Figure 7 Discussion In this work, we have disrupted connections of the gp45 sliding clamp to individual T4 late transcription components, gp55 and gp33, which occupy the sites on RNAP core that bind σ70 domains 2 and 4. We show that the C-terminal motifs of gp33 and gp55, which allow attachment to the sliding clamp, are fully interchangeable (and can also be exchanged for the corresponding epitope of the gp43 DNA polymerase). Nevertheless, the loss of the gp45-gp33 and gp45-gp55 connections has entirely different consequences. Loss of the gp45-gp55 linkage still allows appreciable activation of transcription (although subject to interference by the unmodified αCTD of E. coli RNAP, and only seen cleanly when the interfering DNA interaction is eliminated, as it is with T4-modified RNAP). Loss of the gp45-gp33 connection effectively abolishes transcription. Mutagenesis of the gp33 and gp55 linkers to the sliding clamp yields a complementary picture: the gp33 linker is highly constrained and mutations in it affect transcriptional activation as well as RNAP core-binding functions. We show that partially preopening the promoter compensates for defects generated by severing the gp33 and gp55 connections with the sliding clamp, implying roles for both of these connections in promoter opening. We also show that, surprisingly, fully activated T4 late open promoter complexes form in the presence of a high concentration of heparin. Severing either the gp33 or the gp55 connection to the sliding clamp respectively abolishes or severely diminishes this avid promoter complex formation, and partly preopening the promoter compensates for loss of the gp45-gp55 connection but not the gp45-gp33 connection. The gp45-gp33 connection and a unified model of initiation at the T4 late promoter Gp55, the homologue of □70 domain 2, supports a basal level of specific transcription from T4 late promoters in the absence of gp45. Basal transcription is sustained by a sequence-nonspecific DNA binding site of RNAP core that remains available in gp55 holoenzyme (Nechaev et al, 2006) but is blocked by proteins, such as □70 domain 4 and gp33, that bind to the RNAP □ flap and thereby alter the DNA-binding specificity of RNAP. □ domains 4 enable RNAP holoenzymes to recognize the -35 promoter motif; gp33 prevents RNAP from interacting with unmodified double-stranded DNA (Nechaev et al, 2006). Given that the gp33-gp45 connection is required for transcriptional activation by the gp45 sliding clamp (Figure 1B and 1C
Special kinetic properties of T4 late transcription It is useful to consider the distinctive properties of T4 late transcription in terms of the common steps of transcriptional initiation (Record et al, 1996). Initial recognition of the closed T4 late promoter (Figure 8 Tethering RNAP to the sliding clamp must also change the processivity of DNA scanning to locate the promoter (step 2). However, it is unlikely that more rapid, processive promoter searching contributes to transcriptional activation in vitro, because steps 1 and 2 are not likely to be rate-limiting for transcriptional initiation, especially when relatively short (<1 kbp) templates are used, as is the case in these experiments. Connections of gp45 to gp55 and gp33 in the activated promoter complex together enforce rapid promoter opening (Kolesky et al, 2002), possibly through formation of a compact structure that draws the sliding clamp to the upstream end of the promoter complex (comparable with a model of the gp45-gp43 DNA polymerase holoenzyme; (Trakselis et al, 2001). It is clear that the T4 late transcription system affords ready manipulation of individual interactions within the promoter complex and is therefore a significant addition to the repertoire of experimental systems for analyzing individual steps of transcription initiation such as promoter recognition and promoter opening. Avid promoter complex formation Heparin is a potent polyanionic competitor of DNA for binding RNAP. It is remarkable that activated T4 late promoter complexes form in competition with a high concentration of heparin. This process required all the components and interactions of the T4 late promoter complex, including both linkages to the sliding clamp (Figure 5 Gp33 and late transcription in other T4-group phages Gp33 is a functional chameleon. As the essential mediator of transcriptional activation by the sliding clamp, it provides the simplest and most direct example of coactivator function (Herendeen et al, 1990). Since it also represses basal transcription (Nechaev et al, 2006), it is appropriate to think of it as operating the switch between the two transcriptional initiation pathways (Figure 8 In closing, we briefly consider how transcription of the late genes might be regulated by other T4-family phages. In view of the presence of similar short acidic and hydrophobic motifs at the C-termini of the gp55 and gp33 homologues (Supplemental Figure 1) and of gp43 homologues (JM Nolan, http://phage.bioc.tulane.edu), it is likely that the interactions between T4 gp55-RNAP, gp33 and the sliding clamp that have been dissected in this work play similar or identical roles in the multiplication cycles of the other E. coli phages. The additional implication is that these other multiplication cycles also couple late transcription to concurrent DNA replication. (Only the two-residue shorter C-terminal motifs of RB49 and phi-1 gp33 stand out as potentially different.) The amino acid sequences of the gp55 and gp33 attachment sites on gp45—the monomer-monomer interfaces and the lateral surface patches—vary considerably among these seven phages (Nolan, 2005). We expect that networks of specific amino acid side chain interactions probably are not precisely conserved but that the general mechanism is. Needless to say, these conjectures indicate avenues of further analysis relating to this remarkable system of transcriptional regulation. Materials and Methods Plasmids Plasmids for overproduction of untagged WT E. coli σ70 and its derivative Δ1.1 (amino acids 100-613) have been described (Nechaev et al, 2006). A plasmid for overproduction of σ70 mutant R541C/L607P was a gift from A. Hochschild. Gp33 and gp55 mutants were constructed as derivatives of plasmid pET21-His6-gp33 (Kolesky et al, 2002) and its gp55 counterpart. Plasmids containing the P23 T4 late promoter and an extended -10 promoter were described by Kolesky et al (1999) and Nechaev and Geiduschek (2006), respectively. Proteins The preparation of wild-type gp55 and gp33 (and their mutant derivatives), E. coli RNAP core C-terminally His6-tagged in the β’ subunit, and the T4-modified form of this RNAP core lacking RpbA has been described or referenced (Kolesky et al, 1999). Untagged σ70 and derivatives were overproduced in E. coli BL21(DE3) and purified from inclusion bodies, dissolved in 7M urea-containing denaturing buffer and dialyzed against storage buffer (50% (v/v) glycerol, 40mM Tris-HCl, pH 8.0, 200mM NaCl, 1mM DTT, 1mM EDTA) to final protein concentrations of ~50 μM, as described or referenced for preparation of untagged gp55 (Kolesky et al, 1999). Transcription templates Duplex DNA templates for transcription were prepared by PCR amplification using Vent DNA polymerase. A 126-bp extended -10 promoter fragment (bp -79 to +47) was amplified out of plasmid pE-10 as described (Nechaev et al, 2006). The 166-bp T7A1 promoter fragment yields a 73-nt run-off transcript. Double-stranded, 3′-end recessed T4 late templates were prepared by Exo III treatment as described (Kolesky et al, 2002). Briefly, an ~580-bp PCR fragment containing the P23 T4 late promoter and downstream rrnB terminators amplified from placO-SK110-rrnB (T1+T2) was cleaved with Hind III and Kpn I to generate ExoIII-susceptible downstream and ExoIII-resistant upstream ends and reacted with ExoIII to generate ~100 nt of single-stranded downstream DNA. Transcripts initiating at P23 and terminating at T1 and T2 are ~110 and ~270 nt in length, respectively. Partially heteroduplex and 3′-endrecessed transcription templates were prepared by ligating 3 DNA fragments. The upstream fragment was prepared by PCR-amplifying a gene 33 segment from pET21gp33 and treatment with XhoI. The middle fragment was prepared by annealing synthetic DNA oligonucleotides (5′-unphosphorylated) corresponding to bp -40 to +35 of the P23 promoter with single-stranded ends allowing ligation to XhoI and KpnI sites at its upstream and downstream ends, respectively. The bp -13/-8 promoter mismatch was created by changing the template (transcribed) strand to create AA and TT non-complementarities. The downstream 721-bp fragment was prepared by PCR-amplifying the pE-10 plasmid with the same primers that were used for preparation of 3′-end recessed templates (Kolesky et al, 2002), treating with KpnI and ExoIII to create an ~100-bp single-stranded 3′-end recessed downstream end. The upstream, middle and downstream fragments were combined in molar ratios of 2:1:2, respectively, and joined with T4 DNA ligase at a final concentration of 50 fmol/□l middle fragment. After heat-inactivation at 65°C for 20 min, 1 □l of the ligation mix was used for transcription in each reaction without further purification. In vitro transcription Single-round transcription was carried out at 25°C (except as noted) in Standard Reaction Buffer (Nechaev et al, 2006) containing 200 mM K acetate, 33 mM Tris acetate, pH 7.8, 10 mM Mg acetate, 1 mM DTT, 0.12% (w/v) Tween 20 augmented with 5% (w/v) PEG 3350, except as noted. Standard concentrations of components in the assembled transcription mix were 4 nM DNA, 40 nM RNAP core, a 12-fold molar excess of gp33 and gp55 (each) relative to core, 400 nM (trimer) gp45, 160 nM gp44/62 clamp loader complex, 750 nM gp32 (single-stranded DNA-binding protein), 0.4 mM dATP, 1 mM ATP, GTP, 100 μMPCTP and 100 μM [α-32P]UTP. DNA and gp32 in 10 μL volume were added to all other proteins in 10 μL volume for the times noted for individual experiments before combining with NTPs and heparin in 5 μL volume for 5 min of RNA synthesis. For experiments shown in Figure 3 suff fig 1 Click here to view.(76K, pdf) sugg fig 3 Click here to view.(154K, pdf) supp Click here to view.(51K, doc) supp fig 2 Click here to view.(43K, pdf) supp fig 4 Click here to view.(61K, pdf) supp fig 5 Click here to view.(31K, pdf) supp fig 6 Click here to view.(133K, pdf) Acknowledgements We are grateful to G.A. Kassavetis for many discussions and advice during the course of this work, and to G.A. Kassavetis, M. Ouhammouch and K. Severinov for a critical reading of the manuscript. We also thank R. Gourse and R.M. Saecker for information and L.E. Parker for editorial help and acknowledge support of this research by the National Institute of General Medical Sciences of the NIH. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Cell. 2006 Jun 16; 125(6):1069-82.
[Cell. 2006]Science. 1993 Nov 26; 262(5138):1407-13.
[Science. 1993]J Mol Biol. 1997 Mar 21; 267(1):60-74.
[J Mol Biol. 1997]EMBO J. 2007 Feb 21; 26(4):955-64.
[EMBO J. 2007]Biochem Biophys Res Commun. 1968 Feb 15; 30(3):240-7.
[Biochem Biophys Res Commun. 1968]J Biol Chem. 2003 Feb 28; 278(9):7073-80.
[J Biol Chem. 2003]Proc Natl Acad Sci U S A. 2004 Dec 14; 101(50):17365-70.
[Proc Natl Acad Sci U S A. 2004]Proc Natl Acad Sci U S A. 1984 Aug; 81(16):5101-5.
[Proc Natl Acad Sci U S A. 1984]Nucleic Acids Res. 1986 Aug 26; 14(16):6745-63.
[Nucleic Acids Res. 1986]Science. 1990 May 4; 248(4955):573-8.
[Science. 1990]Science. 1992 May 29; 256(5061):1298-303.
[Science. 1992]EMBO J. 1994 Nov 15; 13(22):5330-7.
[EMBO J. 1994]Cell. 1994 Apr 22; 77(2):225-37.
[Cell. 1994]J Mol Biol. 2000 Mar 10; 296(5):1215-23.
[J Mol Biol. 2000]Cell. 1999 Oct 15; 99(2):155-66.
[Cell. 1999]Virology. 2007 Jun 5; 362(2):384-96.
[Virology. 2007]Mol Biol Evol. 2006 Sep; 23(9):1688-96.
[Mol Biol Evol. 2006]Virol J. 2006 May 23; 3():30.
[Virol J. 2006]J Mol Biol. 2006 Aug 4; 361(1):46-68.
[J Mol Biol. 2006]Proc Natl Acad Sci U S A. 2004 Dec 14; 101(50):17365-70.
[Proc Natl Acad Sci U S A. 2004]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]J Mol Biol. 2002 Aug 30; 321(5):767-84.
[J Mol Biol. 2002]J Mol Biol. 2002 Aug 30; 321(5):767-84.
[J Mol Biol. 2002]J Biol Chem. 1999 Aug 27; 274(35):24485-9.
[J Biol Chem. 1999]J Mol Biol. 1998 Nov 27; 284(2):195-203.
[J Mol Biol. 1998]Trends Biochem Sci. 2001 Sep; 26(9):566-72.
[Trends Biochem Sci. 2001]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]Cell. 1994 Apr 22; 77(2):225-37.
[Cell. 1994]Proc Natl Acad Sci U S A. 2004 Dec 14; 101(50):17365-70.
[Proc Natl Acad Sci U S A. 2004]Eur J Biochem. 1967 Dec; 3(2):194-201.
[Eur J Biochem. 1967]J Biol Chem. 1977 Aug 10; 252(15):5403-7.
[J Biol Chem. 1977]Proc Natl Acad Sci U S A. 2004 Mar 30; 101(13):4554-9.
[Proc Natl Acad Sci U S A. 2004]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]J Mol Biol. 2002 Aug 30; 321(5):767-84.
[J Mol Biol. 2002]J Biol Chem. 2007 Jul 20; 282(29):21319-26.
[J Biol Chem. 2007]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]J Mol Biol. 2002 Aug 30; 321(5):767-84.
[J Mol Biol. 2002]Trends Biochem Sci. 2001 Sep; 26(9):566-72.
[Trends Biochem Sci. 2001]Science. 1990 May 4; 248(4955):573-8.
[Science. 1990]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]J Mol Biol. 2002 Aug 30; 321(5):767-84.
[J Mol Biol. 2002]J Mol Biol. 1999 Aug 13; 291(2):267-81.
[J Mol Biol. 1999]J Mol Biol. 1999 Aug 13; 291(2):267-81.
[J Mol Biol. 1999]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]J Mol Biol. 2002 Aug 30; 321(5):767-84.
[J Mol Biol. 2002]J Mol Biol. 2002 Aug 30; 321(5):767-84.
[J Mol Biol. 2002]EMBO J. 2006 Apr 19; 25(8):1700-9.
[EMBO J. 2006]J Mol Biol. 1999 Aug 13; 291(2):267-81.
[J Mol Biol. 1999]Proc Natl Acad Sci U S A. 2007 May 8; 104(19):7833-8.
[Proc Natl Acad Sci U S A. 2007]